Oncologix Tech Stock Analysis
| OCLG Stock | USD 0.0001 0.00 0.00% |
Oncologix Tech is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Oncologix Tech pink sheet analysis is to determine its intrinsic value, which is an estimate of what Oncologix Tech is worth, separate from its market price. There are two main types of Oncologix Tech's stock analysis: fundamental analysis and technical analysis.
The Oncologix Tech pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Oncologix Tech's ongoing operational relationships across important fundamental and technical indicators.
Oncologix |
Oncologix Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Oncologix Tech had not issued any dividends in recent years. The entity had 1:4 split on the 19th of May 2011. Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.The quote for Oncologix Tech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Oncologix Tech contact the company at 616-977-9933 or learn more at https://www.oclghealth.com.Oncologix Tech Investment Alerts
| Oncologix Tech generated a negative expected return over the last 90 days | |
| Oncologix Tech has some characteristics of a very speculative penny stock | |
| Oncologix Tech has a very high chance of going through financial distress in the upcoming years | |
| Oncologix Tech currently holds 3.97 M in liabilities. Oncologix Tech has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncologix Tech until it has trouble settling it off, either with new capital or with free cash flow. So, Oncologix Tech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncologix Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncologix to invest in growth at high rates of return. When we think about Oncologix Tech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.85 M. Net Loss for the year was (2.37 M) with profit before overhead, payroll, taxes, and interest of 614.41 K. | |
| Oncologix Tech currently holds about 86.31 K in cash with (24.2 K) of positive cash flow from operations. |
Oncologix Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 612.23 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oncologix Tech's market, we take the total number of its shares issued and multiply it by Oncologix Tech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Oncologix Profitablity
The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncologix Tech, as well as the relationship between them.Oncologix Tech Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oncologix Tech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oncologix Tech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Oncologix Tech Outstanding Bonds
Oncologix Tech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oncologix Tech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oncologix bonds can be classified according to their maturity, which is the date when Oncologix Tech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US68233JBV52 Corp BondUS68233JBV52 | View | |
| US68233JBU79 Corp BondUS68233JBU79 | View | |
| US68233JBR41 Corp BondUS68233JBR41 | View | |
| US68233JBP84 Corp BondUS68233JBP84 | View | |
| ONCOR ELEC DELIVERY Corp BondUS68233JBG85 | View |
About Oncologix Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Oncologix Tech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oncologix shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Oncologix Tech. By using and applying Oncologix Pink Sheet analysis, traders can create a robust methodology for identifying Oncologix entry and exit points for their positions.
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Oncologix Tech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Complementary Tools for Oncologix Pink Sheet analysis
When running Oncologix Tech's price analysis, check to measure Oncologix Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncologix Tech is operating at the current time. Most of Oncologix Tech's value examination focuses on studying past and present price action to predict the probability of Oncologix Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncologix Tech's price. Additionally, you may evaluate how the addition of Oncologix Tech to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |